Ranivisio 10 mg/ml, Injektionslösung in einer Fertigspritze - Swissmedic Key 70412001 Registration Holder Bioeq AG Name Ranivisio 10 mg/ml, Injektionslösung in einer Fertigspritze Date of registration 19.12.2025 Introduction of Sequence 19.12.2025 ATC-Classification Ranibizumab (S01LA04) Revision date WHO WHO-DDD Valid until 18.12.2030 Index Therapeuticus (BSV) Show package size Index Therapeuticus (Swissmedic) 11.99. Description Swissmedic categorie. SL Eintrag No Indication Information for professionals IP Consumer information Deductible k.A. Feedback FB GTIN 7680704120018 Medication Code Biotechnologika Pharmacode Disponibility
Composition ranibizumabum 10 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml. Packungsbestandteile Galenic Form Injection solution in prefilled syringe Excipiens Active Agent Dose Ranibizumab 10 mg/ml
Inactive agents Histidin Hydrochloride Monohydrate Histidine Polysorbatum 20 Trehalosum Dihydricum
Source
